Atlas Trials

Expanded Access to Glecaprevir/ Pibrentasvir

Clinical trial NCT03123965 · APPROVED_FOR_MARKETING

Trial details

NCT number
NCT03123965
Sponsor
AbbVie
Status
APPROVED_FOR_MARKETING
Study type
EXPANDED_ACCESS
Hepatitis C Virus Infection

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.